Growth Metrics

Veracyte (VCYT) Amortization of Deferred Charges (2016 - 2019)

Veracyte (VCYT) has disclosed Amortization of Deferred Charges for 7 consecutive years, with $75000.0 as the latest value for Q2 2019.

  • Quarterly Amortization of Deferred Charges rose 837.5% to $75000.0 in Q2 2019 from the year-ago period, while the trailing twelve-month figure was $75000.0 through Mar 2020, up 134.38% year-over-year, with the annual reading at $83000.0 for FY2019, 159.38% up from the prior year.
  • Amortization of Deferred Charges hit $75000.0 in Q2 2019 for Veracyte, up from $8000.0 in the prior quarter.
  • In the past five years, Amortization of Deferred Charges ranged from a high of $393000.0 in Q4 2017 to a low of -$34000.0 in Q4 2015.
  • Historically, Amortization of Deferred Charges has averaged $141722.2 across 5 years, with a median of $19000.0 in 2015.
  • Biggest five-year swings in Amortization of Deferred Charges: tumbled 312.5% in 2015 and later surged 3400.0% in 2016.
  • Year by year, Amortization of Deferred Charges stood at -$34000.0 in 2015, then soared by 1232.35% to $385000.0 in 2016, then rose by 2.08% to $393000.0 in 2017, then tumbled by 97.96% to $8000.0 in 2018, then soared by 837.5% to $75000.0 in 2019.
  • Business Quant data shows Amortization of Deferred Charges for VCYT at $75000.0 in Q2 2019, $8000.0 in Q1 2019, and $8000.0 in Q4 2018.